Switching Off Cancer-Causing Telomerase Using Small Molecules.
Aberrant telomerase activity via the expression of its catalytic subunit hTERT is a hallmark of some malignant cancers. In this issue of Cell Chemical Biology, Song et al. (2019) demonstrate that hTERT downregulation by targeting a repressive DNA motif on the gene promoter using small molecules effectively kills cancer cells.